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Malaria infection is caused by plasmodium species in
mosquitoes; namely falciparium, vivax, ovale, and malar-
iae. These parasites cross the blood brain barrier and infect
the central nervous system as cerebral malaria. It is mostly
disastrous in children and is a common cause of death in
children in Africa. In the past mono-therapy drugs such as
chloroquine and amodiaquine were often used for treat-
ment of cerebral malaria. Recently combination therapy is
the recommended line of treatment for cerebral malaria.
Most of these new drugs have adverse effects on the nerv-
ous system. We studied the reaction of astrocytes in the
hippocampus after three days administration of meflo-
quine and artequin to forty-two Wistar rats. Artequin con-
sist of Mefloquine and artminsinin. Some rats were given
Mefloquine alone while some were given Artequin, which
is the combination therapy drug. Rats in groups A, B and
C received 1.07 mg/kg, 2.14 mg/kg, and 4.28 mg/kg of
mefloquine while rats in groups D, E and F received 0.86/
1.07 mg/kg, 1.71/2.14 mg/kg and 3.24/4.28 mg/kg of
Artequin. Sections of the hippocampus treated with these
drugs and stained with Hortegas lithium carbonate histo-
chemical method revealed that astrocytes stained black as
in the sections of rats from the control group. However
sections from rats treated with 2.14 mg/kg (group B) and
4.28 mg/kg (group C) of mefloquine and 1.71/2.14 mg/
kg (group E) and 3.24/4.28 mg/kg (group F) of artequin
showed large, numerous and some few paired astrocytes.
We conclude that mefloquine and artequin induced dose
dependent reactive astrocyte formation in the hippocam-
pus of rats. This may impair uptake of neurotransmitters
and alter neuronal environment. The functions of hippoc-
ampus such as learning and memory may be affected. We
suggest that the use of new combination therapy to treat
cerebral malaria should be recommended with caution.
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